Risk factors for bone metastasis from renal cell cancer

Objective The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. In this study, we investigate the correlation between diverse clinical factors and bone metastases secondary from renal cell cancer (RCC), and to identify potential risk factors for bone metastasis in newly diagnosed patients and those who have already received treatment. Methods The clinical data of 372 patients with RCC were reviewed from January 2000 to August 2016. The correlations between age, gender, histopathologic types, alkaline phosphotase (ALP), CEA, AFP, CA-125, CA-153, CA-199, calcium, hemoglobin (HB) and bone metastases were analyzed. And the risk factors for bone metastases in RCC were identified by multivariate logistic regression analysis. The cutoff value, sensitivity and specificity of the independent correlation factors were calculated by receiver operating characteristic (ROC) curve. Results The bone is the second to the lung as a distant metastasis target site in patients with RCC. Thirty eight individuals were identified with bone metastases. Of these patients, significantly higher levels of ALP, calcium, HB were found than those without bone metastasis (P < 0.05, respectively). No significant differences were detected in CEA, AFP, CA-125, CA-153, CA-199, age, gender and histopathologic types between patients with and without bone metastases (P > 0.05, respectively). Multivariate logistic regression analysis indicated that ALP, calcium and HB were independent risk factors correlated with bone metastasis (P < 0.05, respectively). ROC curves demonstrated these factors had comparable accuracy at predicting bone metastasis (AUC were 0.749, 0.633 and 0.665, respectively). The cutoff values of ALP, calcium and HB were 105.5 U/L, 2.615 mmol/L and 111.5 g/L, respectively. The sensitivities of them were 57.9%, 36.8% and 71.1% for predicting bone metastasis, with specificities of 83.5%, 95.2% and 65.3%, respectively. Conclusion Based on our study, the concentrations of ALP, calcium and HB were potentially risk factors for bone metastasis in patients with RCC. For newly diagnosed patients, if the values of ALP>105.5 U/L, calcium>2.615 mmol/L and HB<111.5 g/L were detected, intensive monitoring and bone scanning are warranted for them.

[1]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[2]  K. Junker,et al.  High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor , 2014, Molecular Cancer.

[3]  T. Jang,et al.  Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach , 2017, Front. Oncol..

[4]  R. Reis,et al.  Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib. , 2018, Urologic oncology.

[5]  William Hollingworth,et al.  A systematic review of geographical variation in access to chemotherapy , 2015, BMC Cancer.

[6]  장윤희,et al.  Y. , 2003, Industrial and Labor Relations Terms.

[7]  M. Kunimatsu,et al.  Human prostate cancer cells adhere specifically to hemoglobin: a possible role in bone-specific metastasis. , 2001, Cancer letters.

[8]  J. Ying,et al.  A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer , 2017, International Journal of Clinical Oncology.

[9]  F. Hamdy,et al.  Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer , 2016, British Journal of Cancer.

[10]  P. Kuo,et al.  Bone Metastasis from Renal Cell Carcinoma , 2016, International journal of molecular sciences.

[11]  M. Menon,et al.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  R. Kapoor,et al.  Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation , 2014, The Indian journal of medical research.

[13]  H. You,et al.  Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma , 2017, Oncotarget.

[14]  S. Girgis,et al.  Review of renal cell carcinoma and its common subtypes in radiology. , 2016, World journal of radiology.

[15]  Joo Hoon Kim,et al.  Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients , 2016, BMC Cancer.

[16]  J. Karam,et al.  Role of targeted therapy in combination with surgery in renal cell carcinoma , 2016, International journal of urology : official journal of the Japanese Urological Association.

[17]  C. Boudot,et al.  Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation , 2017, Oncotarget.

[18]  Janet E Brown,et al.  Skeletal metastasis in renal cell carcinoma: current and future management options. , 2012, Cancer treatment reviews.

[19]  S. Bavbek,et al.  Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma. , 2013, Current oncology.

[20]  Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer , 2017, Scientific Reports.

[21]  Ping Huang,et al.  Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer , 2017, PloS one.

[22]  H. Nishimatsu,et al.  Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? , 2011, The Journal of urology.

[23]  W. Brenner,et al.  The role of extracellular calcium in bone metastasis , 2016, Journal of bone oncology.